AKYA — Akoya Biosciences Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall CapSucker Stock
- $208.93m
- $213.28m
- $74.86m
- 38
- 16
- 40
- 21
Annual income statement for Akoya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 42.2 | 42.4 | 54.9 | 74.9 |
| Cost of Revenue | ||||
| Gross Profit | 24.7 | 25.9 | 34.2 | 43.4 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 54.5 | 56.1 | 91.7 | 141 |
| Operating Profit | -12.3 | -13.7 | -36.8 | -66.1 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -14.6 | -16.7 | -43.1 | -70.5 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -14.8 | -16.7 | -42.9 | -70.6 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -14.8 | -16.7 | -42.9 | -70.6 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -18.3 | -21.8 | -44.4 | -70.6 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.513 | -0.579 | -1.71 | -1.87 |
| Dividends per Share |